Search Results
Non-viral gene delivery & gene editing: highlights from ESGCT
Highlights from ESGCT 2021: gene therapy clinical data, advances in gene editing & AAV toxicity
ESGCT e-School: Learn from viruses to improve viral and non-viral vectors
ESGCT e-Seminar: Virus-free gene editing of T cells
ESGCT 2021 highlights: AAV vector capsid modification for CNS disorders
New delivery vehicles for gene editing enzymes
ESGCT e-School: Gene Therapy – From Concept to Proof
ESGCT e-Seminars: Intellia’s Modular CRISPR/Cas9 Gene Editing Platform for the Treatment of Disease
New era of non-viral DNA-delivered gene therapy seen emerging. With Diem Nguyen, PhD.
Gene Editing - from experimental to clinical trials
ESGCT e-School: What you should know about producing gamma and lentiviral vectors
ESGCT 2017 Education Day - Zsuzsanna Izsvak
